Company: LLOBF
Filing Date: 2025-10-29
Form Type: 424B2
Source: 0000950103-25-013799
Chunk: 12

Company: Lloyds Banking Group plc
Filing Date: 2025-10-29
Form: 424B2
Chunk 12
---
FA”), we have determined, and hereby notify
all relevant persons (as defined in Section 309A(1) of the SFA) that the Senior Notes are “prescribed capital markets products”
(as defined in the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore) and “Excluded Investment Products”
(as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment
Products).

<div align='center'>Notice to Canadian investors</div>

The Senior Notes may be sold in Canada only to
purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106
Prospectus Exemptions (“NI 45-106”) or subsection 73.3(1) of the Securities Act (Ontario), and are permitted
clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations (“NI
31-103”) and that are not created or used solely to purchase or hold securities as an accredited investor described in paragraph
(m) of the definition of “accredited investor”.

The offer and sale of the Senior Notes in Canada
is being made on a private placement basis only and is exempt from the requirement that we prepare and file a prospectus under applicable
Canadian securities laws. Any resale of the Senior Notes must be made in accordance with applicable Canadian securities laws, which may
vary depending on the relevant jurisdiction, and which may require resales to be made in accordance with an exemption from, or in a transaction
not subject to, the prospectus requirements of applicable securities laws. These resale restrictions may under certain circumstances apply
to resales of the Senior Notes outside of Canada.

Securities legislation in certain provinces or
territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement or the accompanying
prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised
by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser
should refer to any applicable provisions of the securities legislation of the purchaser’s province or territory for the particulars
of these rights or consult with a legal advisor.

Pursuant to section 3A.3 of National Instrument
33-105 Underwriting Conflicts (“NI 33-105